Bristol-Myers Squibb | BMY | Long Position at $40

Bristol-Myers Squibb BMY has not deviated this far my selected simple-moving average since the early 2000s. It is currently in a personal buy zone in the low 40s. It may trade sideways for some time, but my hope is patience pays off (including the dividend).

Target #1 = Gap fill to $56.
Target #2 = Gap fill to $70.
Note
Target #1 reached for a 40% gain.
Chart PatternsTechnical IndicatorsTrend Analysis

Aussi sur:

Clause de non-responsabilité